UiPath (NYSE: PATH) Stock Analysis: UBS Cuts Price Target, Needham Remains Bullish on AI Growth

Font: Financial Modeling Prep  • Sep 25, 2026

• UBS maintained a Neutral rating on UiPath and lowered its price target to $15.00 from $19.00, reflecting caution after the company’s Investor Day and its fiscal 2028 outlook. 
• Needham analyst Scott Berg maintained a Buy rating with a more optimistic $22.00 price target, citing UiPath’s AI automation opportunity and product innovation around tools such as Cartographer and Test Cloud. 
• UiPath’s stock was recently quoted at $12.60 per share, down $0.44, or 3.37%. That level also implies a roughly 24% decline from its August 25 close of $16.66. 

UiPath (NYSE: PATH) is a leading business automation software company known for robotic process automation and AI-enabled workflow tools. It operates in a competitive enterprise software market alongside companies such as ServiceNow and Pegasystems.

UBS recently maintained its Neutral rating on UiPath while lowering its price target to $15.00 from $19.00. A Neutral rating generally suggests that analysts expect the stock to perform broadly in line with the market or sector. The reduced target followed UiPath’s Investor Day, where UBS pointed to limited visibility around longer-term annual recurring revenue growth.

This cautious view contrasts with Needham’s more positive stance. Needham analyst Scott Berg maintained a Buy rating and a $22.00 price target following UiPath’s Analyst Day at its Fusion 2026 conference. Berg highlighted the company’s expanding opportunity in AI automation, including products such as UiPath Cartographer, Maps, and Test Cloud.

UiPath also announced new AI-focused product developments at Fusion 2026. Cartographer is designed to help enterprises map and govern how business processes actually run, while Test Cloud is being enhanced with autonomous testing capabilities. 

Despite those product announcements and bullish analyst commentary from Needham, UiPath shares remain under pressure. The stock recently traded at $12.60, down 3.37% on the day, extending a roughly 24% monthly decline. This reflects the market’s ongoing concern about growth visibility, even as analysts remain divided on UiPath’s long-term AI-driven potential.